DNMT3A and coronary artery disorder: While other CHIP driver mutations, including TET2, associate with adverse cardiovascular outcomes among individuals with prevalent atherosclerosis, DNMT3A seems not to confer the same risk, although some studies did show a weak association with elevated incident coronary heart disease (32,33).